Registry data as of Aug 27, 2026

Ivan Castillo-Salazar, MD

Ophthalmology Physician · Waco, TX

Ivan Castillo-Salazar, MD is an ophthalmology physician with a practice address in Waco, Texas, and NPI 1316155443, issued on May 21, 2007. Check the license (Texas M7090, as entered in NPPES) on the Texas Medical Board; the Medicare figures below come from public CMS files.

Record from CMS NPPES, loaded Aug 27, 2026 · Medicare files 2023 and 2024 · method · Verify with CMS →

NPPES recordas of Aug 27, 2026
1316155443
Name
Ivan Castillo-Salazar
Credential
MD
Primary taxonomy
Ophthalmology Physician 207W00000X
License number
M7090 TX
Self-reported in NPPES; status is on the state search
Practice location
7030 New Sanger RD Ste 102, Waco, TX 76712
Phone
(254) 753-7007
Enumerated
May 21, 2007
Entity
Type 1 · individual
Public record from CMS NPPES (open it on the CMS NPI Registry). A record is not a license: verify it with the state board.
Download card Updates feed

Verify Ivan Castillo-Salazar in five checks

  1. 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
  2. 2LicenseActive license and public ordersTexas Medical Board
    Search for license M7090
    Check the board
  3. 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
  4. 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
  5. 5CertificationBoard certificationABMS, AOA, NCCPA, AANPNot checked
Open the Texas license search

PlainDoctor does not match the HHS-OIG exclusion list to individual records: most entries carry no NPI. Search the OIG exclusion list by name.

32% fewer Medicare Part D claims than the average ophthalmology physician in 2024

1,011 Medicare Part D claims for 282 beneficiaries, against an average of 1,490 among the 16,109 providers of this specialty who prescribed in Part D. Brand-name drugs were 25% of claims.

  1. Ivan Castillo-Salazar1,011
  2. Specialty average1,490

Most prescribed

  1. Prednisolone Acetate136 claims
  2. Brimonidine Tartrate132 claims
  3. Latanoprost132 claims
  4. Dorzolamide-Timolol119 claims
  5. Bromfenac Sodium83 claims
  6. Dorzolamide Hcl77 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

The practice group's Medicare quality score for 2023: 97.9 of 100

The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.

  1. Qualityout of 100 · 30% of the final score97.9
  2. Costout of 100 · 30%
  3. Promoting interoperabilityout of 100 · 25%97.0
  4. Improvement activities40 of 40 points · 15%100.0

Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).

Industry payments in 2024: $2,129.55

70 payments, mostly food and beverage; the largest payer was Regeneron Healthcare Solutions, Inc.. The 12,922 providers of this specialty with any payment received $4,937.17 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.

  1. Ivan Castillo-Salazar$2,129.55
  2. Specialty average$4,937.17

Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.

One hospital or facility affiliation

  1. Texas Retina AssociatesWoodway, TX

Source: CMS Doctors and Clinicians affiliations; Hospital General Information (Care Compare) (data.cms.gov). Star ratings are CMS hospital ratings, not ratings of this provider.

Ophthalmology Physician providers in Texas

There are 1,439 ophthalmology physician records in Texas.

Other ophthalmology physician records in Texas

  1. Justin Aaker, MDGeorgetown, TX1144422908
  2. Asad Abbas, M.D.Baytown, TX1457354813
  3. Ashkan Abbey, M.D.Dallas, TX1548402886
  4. Meredith Abbott, MDDallas, TX1659570943
  5. Musa Abdelaziz, MDSouthlake, TX1588906465
  6. Wael Abdelghani, M.D.The Woodlands, TX1508837915
  7. Aziz Abdul-Rahim, M.D.Fort Worth, TX1881690279
  8. Saeid Abedin, M.D.,Houston, TX1265470819
  9. Joan Abernethy, MDFort Worth, TX1871590471
  10. Mohamad Bachir AbiadDallas, TX1831542828

Common questions

What is Ivan Castillo-Salazar, MD's NPI number?

Ivan Castillo-Salazar, MD's National Provider Identifier (NPI) is 1316155443, issued on May 21, 2007. An NPI identifies a provider in billing; it is not a license.

Where is Ivan Castillo-Salazar, MD located?

The NPPES record lists a practice address at 7030 New Sanger RD Ste 102, Waco, TX, 76712. Phone: (254) 753-7007. Providers update this record themselves, so call before visiting.

How can I verify Ivan Castillo-Salazar, MD's license?

NPPES lists Texas license number M7090, as entered by the provider. Search the Texas Medical Board at https://profile.tmb.state.tx.us/Search.aspx. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.

How much does Ivan Castillo-Salazar, MD prescribe under Medicare Part D?

In 2024, Ivan Castillo-Salazar, MD had 1,011 Medicare Part D claims for 282 beneficiaries; the average among ophthalmology physician prescribers was 1,490. Part D covers Medicare prescriptions only.

What is Ivan Castillo-Salazar, MD's Medicare quality score?

The 2023 MIPS final score is 97.9 of 100, reported for the practice group. The average among 454,083 clinicians with a measured score was 83.5.

Source: CMS National Plan and Provider Enumeration System (NPPES), loaded Aug 27, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 27, 2026.